CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax (Deprecated 2012-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax (Deprecated 2012-01-31) of $1.58 million for the 12-month period ending 2012-12-29, per its 10-K filed 2013-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTax · last filed 2013-02-27
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for the quarter ending 2012-12-29 was $780.00K, a 88.56% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for the quarter ending 2012-09-29 was $216.00K, a 86.21% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $233.00K, a 959.09% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $350.00K, a 153.62% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for fiscal 2012 was $1.58M, a 77.74% decline from fiscal 2011.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for fiscal 2011 was $7.09M, a 113.42% increase from fiscal 2010.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, tax (deprecated 2012-01-31) for fiscal 2010 was $3.32M.
| Period end | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-29 | $780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $996.00K derived: sum of 2 quarters · filed 2013-02-27 | $1.23M derived: sum of 3 quarters · filed 2013-02-27 | $1.58M 10-K · filed 2013-02-27 |
| 2012-09-29 | $216.00K 10-Q · filed 2012-11-01 | $449.00K derived: sum of 2 quarters · filed 2012-11-01 | $799.00K 10-Q · filed 2012-11-01 | $7.62M derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-06-30 | $233.00K 10-Q · filed 2012-08-07 | $583.00K 10-Q · filed 2012-08-07 | $7.40M derived: sum of 3 quarters · filed 2013-02-27 | $7.51M derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-03-31 | $350.00K 10-Q · filed 2012-05-04 | $7.17M derived: sum of 2 quarters · filed 2013-02-27 | $7.28M derived: sum of 3 quarters · filed 2013-02-27 | $7.30M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $6.93M derived: sum of 2 quarters · filed 2013-02-27 | $6.95M derived: sum of 3 quarters · filed 2013-02-27 | $7.09M 10-K · filed 2013-02-27 |
| 2011-09-24 | $116.00K 10-Q · filed 2012-11-01 | $138.00K derived: sum of 2 quarters · filed 2012-11-01 | $276.00K 10-Q · filed 2012-11-01 | |
| 2011-06-25 | $22.00K 10-Q · filed 2012-08-07 | $160.00K 10-Q · filed 2012-08-07 | ||
| 2011-03-26 | $138.00K 10-Q · filed 2012-05-04 | |||
| 2010-12-25 | $3.32M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |